Ignite Creation Date:
2024-05-06 @ 3:14 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02249221
Status:
COMPLETED
Last Update Posted:
2014-12-05
First Post:
2014-09-23
Brief Title:
Safety Tolerability and Immunogenicity of GC3106 Quadrivalent Cell-culture Based Influenza Vaccine
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp